Prediction: Occidental Petroleum Stock Is a Buy Before May 6

Occidental is expected to report Q1 adjusted EPS of $0.70 on May 6, with the article arguing the company can beat consensus on stronger oil and gas prices, efficiency gains, and debt reduction following the $9.7 billion OxyChem sale. Berkshire Hathaway’s 26.7% stake is cited as an additional positive signal. The piece is largely bullish commentary rather than new company disclosure, so near-term market impact is likely limited.

Analysis

The setup is less about a one-day earnings beat and more about a balance-sheet inflection. The cash proceeds from the divestiture create optionality that the market usually underwrites slowly, so the likely second-order effect is multiple expansion if management frames debt paydown as durable rather than tactical. That matters because in capital-intensive upstream, a cleaner balance sheet can compress equity risk premium faster than a modest EPS beat can move the stock.

The most important read-through is not OXY alone but the signal to the rest of the complex: if a large, asset-heavy producer can monetize non-core assets and still maintain production discipline, peers with weaker leverage will be forced to choose between buying back stock and preserving liquidity. That can support the group in the near term, but it also widens dispersion between integrateds with balance-sheet flexibility and smaller producers that lack that option. The real beneficiary of any positive surprise is likely BRK.B, because the market will increasingly view the stake as a quasi-preferred claim on deleveraging and free-cash-flow recovery.

The consensus mistake is probably timing. Investors are treating geopolitical oil strength as a short-term revenue boost, but the more durable catalyst is 2H and 2026 capital allocation if management uses the window to de-risk the equity story. The counter-risk is that the market has already repriced OXY for higher crude, so a clean report without an aggressive capital-return roadmap could trigger a classic sell-the-news reaction over 1-3 sessions even if fundamentals are good.

The contrarian angle is that the current move may be over-owned but under-hedged. If oil fades after the quarter and management avoids signaling faster buybacks or debt reduction, the stock could give back a meaningful portion of the year-to-date gain. In that scenario, the better trade is not to chase outright beta but to express a relative view on balance-sheet quality versus pure price leverage.

Key Decisions for Investors

• Go long OXY into the print with a 1-2 week horizon, but size it as a catalyst trade rather than a core holding; target upside if management prioritizes debt reduction and FCF conversion, stop if the call is positive on EPS but vague on capital allocation.
• Buy BRK.B on any post-earnings dip in OXY; the embedded optionality improves if OXY uses proceeds to de-lever, and the stake becomes more valuable as equity risk premium compresses over the next 1-2 quarters.
• Pair trade: long OXY / short a levered E&P basket or weak-capitalized peers for 1-3 months; this isolates the deleveraging and asset-sale story from broad oil price beta.
• For options, consider an OXY call spread expiring just after the earnings call; the setup is favorable if the stock gap is driven by guidance on free cash flow rather than just the headline EPS print.
• Avoid chasing the move if OXY has already rallied sharply into the release; the asymmetric risk is a sell-the-news reaction if the update confirms expectations but fails to raise the capital-return narrative.